RGLS

Regulus Therapeutics
RGLS

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

RGLS was delisted on the 24th of June, 2025.

Back to rankings

36 hedge funds and large institutions have $35.1M invested in Regulus Therapeutics in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 11 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

71% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 14

Holders
36
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$94.2K
2
+$58K
3
+$14.6K
4
PAM
Panagora Asset Management
Massachusetts
+$8.4K
5
TSS
Two Sigma Securities
New York
+$3K

Top Sellers

1
-$2.31M
2
-$486K
3
-$330K
4
SDIC
South Dakota Investment Council
South Dakota
-$261K
5
DS
DRW Securities
Illinois
-$89K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$3K
27
$3K
28
$2K
29
$2K
30
$396
31
$1
32
–
33
–
34
–
35
–
36
–
37
–
38
–
39
–
40
–
41
–
42
–
43
–
44
–
45
–
1
2